Key takeaways
Olidia PLLA is a biostimulator that drives collagen production over 6 to 12 weeks, so volume builds gradually instead of appearing on the day.
Each vial holds a 365mg lyophilized powder cake, made up of 150mg of PLLA, 90mg of carboxymethylcellulose and 125mg of mannitol. Nothing arrives pre-mixed.
Reconstitute with 5 to 7ml of sterile water or saline, then leave the vial undisturbed for about two hours. Short hydration is a known nodule risk.
Once reconstituted, the suspension stays usable for up to 72 hours, so you can mix ahead of the appointment rather than during it.
Results show at 3 to 4 weeks and peak at 8 to 12 weeks. Most protocols run 2 to 3 sessions spaced 4 weeks apart.
Pabau, our practice management software, plots injection sites, tracks results across sessions and sends aftercare messages automatically.
Download your free Olidia PLLA aftercare instructions template
A patient-ready handout phased across the first 24 to 48 hours, the first week and the first month. It covers cold compress use, heat, sun and activity limits, the side effects to expect, and when to call you. It closes with a confirmation line the patient signs. Hand it out before they leave the treatment room.
Download templateOlidia PLLA gives aesthetic practices a collagen-stimulating alternative to hyaluronic acid fillers. It arrives as a freeze-dried powder rather than a ready-to-inject gel. That single detail shapes the whole appointment, because the vial has to be mixed and left to hydrate before anyone picks up a needle.
This guide covers reconstitution, hydration time, injection depth, treatment areas and the results timeline. It also covers the aftercare instructions and the treatment records that keep a multi-session PLLA plan defensible.
What is Olidia PLLA filler?
Olidia PLLA is a poly-L-lactic acid biostimulator. It prompts the patient’s own collagen production instead of adding volume on the day, which is what a hyaluronic acid filler does.
Each vial holds a 365mg lyophilized cake rather than a liquid. That cake is 150mg of PLLA, 90mg of sodium carboxymethylcellulose and 125mg of mannitol. The PLLA microparticles measure roughly 40 to 63 micrometers, small enough for fine needles and large enough to resist immediate phagocytosis.
Because the product ships dry, you set the final concentration yourself. The diluent volume you choose, and the time you give the powder to hydrate, decide how the suspension behaves in the tissue.
Over 6 to 12 weeks the PLLA is absorbed. As it goes, it keeps stimulating fibroblasts to build new collagen fibers around the deposit. The result is volume that improves progressively and holds for far longer than hyaluronic acid, typically 18 to 24 months.
Olidia is made by PRP Life Sciences in South Korea, with Korean MFDS approval and a CE mark. It does not hold FDA approval for aesthetic use in the United States. Confirm what your own regulator allows before you order.
Olidia sits in the same category as Sculptra, one of several trending filler treatments patients now ask for. Whichever product you stock, the consultation carries the same load. Use structured intake forms to record pre-treatment status and to set collagen-stimulation expectations in writing.

What is included in the patient handout?
The download is a patient handout, not an internal protocol. It translates the clinical detail on this page into plain instructions a patient can follow at home.
- Immediate aftercare, first 24 to 48 hours: cold compress timing, gentle cleansing, and limits on heat and pressure.
- The first week: SPF, makeup, hydration, and the alcohol and exercise limits that keep swelling down.
- The first month: gentle skincare, what to watch for on the treated area, and attending the follow-up.
- Common side effects: redness, swelling, bruising, tightness and temporary lumps, each with how long it should last.
- When to contact the practice: severe pain, signs of infection, allergic reaction, and side effects that persist or worsen.
- Long-term care and a confirmation line: lifestyle guidance, plus a statement the patient signs to say they read it.
Hand it over at checkout and keep a record that you did. The handout stops short of the massage schedule, so give patients that part yourself. Repeat it in the follow-up message once the numbing has worn off.
Your own session note stays separate from the patient’s copy. Record the vial, the diluent volume and the treated sites there, in the format a progress note template already sets out.
Olidia vs Sculptra: key differences
Both products are lyophilized PLLA biostimulators, and both work through neocollagenesis. The differences that matter in practice are the mix protocol, the regulatory status and the paperwork behind each one.
The mechanism is the same, so the choice usually comes down to availability, price and what your regulator permits. Where Olidia is available, it carries the same 150mg PLLA dose per vial as the branded alternative.
Olidia reconstitution and injection protocol
Reconstitution is the cornerstone of safe PLLA administration. Under-dilution and short hydration both raise nodule risk. Over-dilution wastes product and dilutes the collagen response. Follow the steps below in order.
- Assess patient history. Review contraindications such as active inflammation, pregnancy and keloid tendency. Document the baseline with structured pre-treatment consultations. Take consent that covers the gradual timeline and the multi-session commitment.
- Prepare the vial. Take the Olidia vial from storage and check the label, the expiry date and the seal. The contents should be a dry, intact white cake. Work aseptically from here on.
- Draw the diluent. Use 5 to 7ml of sterile water for injection or 0.9% normal saline per 365mg vial. Many protocols use 7ml of saline plus 1 to 2ml of lidocaine, which gives about 9ml of suspension. That fills roughly three 3ml syringes.
- Add the diluent slowly. Introduce it down the wall of the vial with a sterile syringe and a wide-bore needle. Let the vacuum draw it in rather than forcing it. Forcing it whips air into the powder and creates foam.
- Let the powder hydrate for about two hours. Leave the vial undisturbed and do not shake it. Full hydration takes roughly two hours, not minutes. Injecting a partly hydrated suspension leaves dry particle clumps in the tissue, which is a known driver of nodules and granulomas.
- Check the suspension. A fully hydrated vial looks evenly milky and opaque, with no visible clumps or grit on the glass. Roll the vial gently between your palms to even it out before you draw. If clumps remain, give it longer.
- Use it within 72 hours. Once reconstituted, the product stays usable for up to 72 hours if it is stored as the supplier directs. Label the vial with the mix date and time. Discard it after that window.
- Load the treatment syringes. Draw the suspension into sterile 3ml or 1ml syringes through a 25-gauge needle. Pre-load every syringe you expect to need, so the vial is opened once.
- Select injection depth. Olidia goes into the subcutaneous plane, at the dermal-hypodermal junction or a little deeper. Never inject it superficially. A 25-gauge needle or a blunt cannula both work, and many practitioners prefer a cannula for broader spread and less bruising.
- Mark and record injection sites. Use Pabau’s injection-plotting feature to log anatomical landmarks, depth and volume per site. That map keeps sessions consistent and makes photo comparison meaningful.
- Inject incrementally. Deposit small aliquots of 0.1 to 0.5ml per pass, fanning across depths and angles. Avoid a bolus in one spot, because spread deposits stimulate a broader collagen response. A typical full-face session uses 2 to 4ml of suspension.
- Massage in the treatment room. Massage each site for 5 to 10 minutes with firm circular pressure. This spreads the microparticles and lowers nodule risk. Tell the patient to leave the area alone for the first 6 to 24 hours, until the numbing wears off and swelling settles. The home routine starts after that and runs for five days.
The two-hour wait belongs in the appointment schedule rather than the treatment room. Mix the vial before the morning session block, or at least two hours ahead of the appointment. Record the mix time in the patient’s notes. Rushing the mix on the day is how a suspension ends up under-hydrated.
Recommended treatment areas
Olidia PLLA is used across the zones below. Each area has its own aesthetic goal and needs a technique adjustment. Check your product license, because some of these uses are off-label in most markets.
- Mid-face volumization: cheeks, temples and lateral nasolabial folds. The gradual collagen response suits age-related volume loss in the mid-face particularly well.
- Lower face definition: jawline contouring and chin projection. Deposits in the pre-jowl sulcus and chin sharpen definition across several sessions.
- Forehead and brow: softening horizontal lines and supporting the brow. PLLA stimulation improves skin quality and underlying support here.
- Neck and decolletage: crepey texture and fine lines. Biostimulation gives skin practices a non-ablative option that builds over 3 to 4 months.
- Hands and body: hand rejuvenation and body skin quality. Hands are increasingly popular, because the collagen response addresses both texture and volume loss.
- Combination plans: PLLA pairs well with energy-based and toxin treatments, so line the recovery windows up before you book. Morpheus8 aftercare runs on its own timeline, and two sets of instructions should not contradict each other. Keep before-and-after photography consistent so cumulative results stay visible.
Olidia before and after: what to expect
Managing expectations decides retention on a biostimulator. PLLA results follow a predictable timeline, so share it before the first injection.
Day 1: mild swelling and erythema at the injection sites. Most patients return to normal activities the same day.
Weeks 1 to 2: bruising resolves and swelling settles. Patients may notice a slight texture change as the microparticles integrate. There is no volume yet, and they need to hear that in advance.
Weeks 3 to 4: the early collagen response becomes visible. Skin texture improves first and subtle volume follows. Patients often say their skin looks fresher before any change in contour shows.
Weeks 8 to 12: peak results. Volume, skin quality and definition reach their maximum. This is the point to assess whether another session is needed.
Sessions and retreatment: most protocols run 2 to 3 sessions spaced 4 weeks apart. Personalized treatment planning based on baseline volume loss sets the session count. After the initial series, patients usually return for a top-up every 12 to 18 months.
Duration: results typically last 18 to 24 months. Longevity varies with metabolism, lifestyle and individual collagen response. Maintenance sessions extend results beyond that window.
Aftercare instructions for patients
Aftercare on a biostimulator asks more of the patient than a hyaluronic acid filler does. With Belotero aftercare, the patient avoids pressure on the area and waits. With PLLA, the massage routine is part of the treatment, and nodule rates reflect how well you explain it.
- Leave the area alone at first: no touching or massage for the first 6 to 24 hours. Wait until the numbing wears off and the swelling settles.
- Then massage as directed: five minutes, five times a day, for five days. Firm circular pressure over every treated area, with clean hands each time.
- Cool, do not heat: a cool pack for 10 minutes at a time in the first 24 hours. No saunas, steam rooms or hot yoga for 48 hours.
- Skip strenuous exercise for 24 to 48 hours, and avoid alcohol for 24 hours. Both increase swelling and bruising.
- Sleep on your back for the first two nights, so nothing presses on the treated area.
- Hold off on makeup for 12 hours, and on facials, peels, microneedling and lasers for two weeks.
- Protect from sun: daily broad-spectrum SPF, and no sunbeds while the area is healing.
- Expect gradual change: volume appears from week three and peaks between weeks eight and twelve.
- Call the practice about severe pain, signs of infection such as spreading redness or pus, or a lump that does not settle.
Patients follow instructions better when they can see where each one sits in the recovery. The timeline below pairs the routine with what the tissue is doing at each stage.

Handing this over verbally is where compliance leaks. Send a written follow-up as well, timed to the days when the massage routine matters most. A patient visit summary keeps the session details and the aftercare in one place.
Safety profile and potential side effects
PLLA biostimulators have a strong safety record when they are mixed and injected correctly. Practitioners still need to recognize the adverse events and know the prevention strategy for each one.
- Nodule formation: small palpable bumps at the injection sites, usually transient. Causes include short hydration, under-dilution, injection that is too superficial and inadequate massage. Prevention: give the vial its full two hours, dilute to protocol, inject subcutaneously and massage thoroughly in the room. The patient then rests the area for 6 to 24 hours before starting the five-day home routine.
- Granuloma: a risk documented for PLLA fillers. Granulomas are rare, under 1% with sound technique, and present as firm localized lumps weeks or months later. They respond to intralesional corticosteroid injection or to observation. Prevention: strict asepsis, full hydration, correct dilution, thorough massage and honest timelines so nobody re-treats out of impatience.
- Bruising and ecchymosis: expected with needle injection and reduced with a cannula. It typically resolves within 7 to 10 days.
- Swelling and erythema: a normal inflammatory response. It peaks at 24 to 48 hours and settles by day 5 to 7.
- Hypersensitivity reactions: rare, since PLLA is highly biocompatible. Reactions to the product or the diluent are still possible, so keep emergency protocols, antihistamines and epinephrine to hand.
- Infection: uncommon where aseptic technique holds. Teach the patient the signs and give aftercare that explains when to make contact.
Read the manufacturer instructions for the vial in front of you. Check current guidance from bodies such as the European Academy of Dermatology and Venereology as well. Protocol detail differs between PLLA products, so never carry one brand’s mixing instructions across to another.
Clinical documentation and record-keeping for Olidia treatments
A biostimulator plan runs across months, so the record has to carry more than a date and a volume. If a nodule appears at week six, these fields are what let you reconstruct the session.
- Product and batch: product name, batch or lot number and expiry date for every vial used.
- Reconstitution parameters: diluent type, diluent volume, any lidocaine added, the mix time and the hydration time before injection.
- Injection map: site, plane, needle or cannula, and volume deposited per site.
- Photography: standardized baseline and follow-up images at the same angle, distance and lighting.
- Consent and counseling: the consent version signed, plus what was said about the gradual timeline and session count.
- Aftercare issued: which handout the patient received, when, and whether they acknowledged it.
- Follow-up and events: review dates, patient-reported concerns, and any adverse event logged on an incident form with its management.
Keeping this in structured client records rather than free-text notes serves two purposes. It supports continuity across the treatment series, and it stands up if a complaint ever lands. Solo injectors gain the most, which is why the practice in our Kingswood Aesthetics case study moved off paper.
How Pabau documents Olidia sessions and automates aftercare
Most med spas run a PLLA series across three systems. The consent sits in a folder and the injection map is a sketch in a paper chart. The aftercare reminder depends on someone remembering to text. By session three, nobody can say which vial went where.
Pabau, our practice management software, keeps the series in one client record. Injection plotting logs each depot against an anatomical map, so the next session starts from what you actually did. Before-and-after photos sit in the same record, which makes the week-eight comparison a two-second job instead of a hunt through a phone.
The aftercare side runs on a schedule you set once. Consent and intake forms go out digitally before the appointment. The handout goes out at checkout, and the massage reminders start the next day, once the rest window has passed.
Every subscription includes every feature, so the plotting, the forms and the automated messaging sit in the plan you are already on.
The outcome is a treatment series you can defend and a patient who follows the massage routine. That combination is what keeps nodule rates low and brings patients back for the maintenance session.
Document every PLLA session in one record
Plot injection sites, store baseline and follow-up photos, and send Olidia aftercare and massage reminders automatically. Your practice keeps a defensible record of every vial and every visit.
Conclusion
Olidia PLLA rewards patience more than technique alone. Two decisions separate a clean result from a nodule, and both are made before the needle comes out. The first is how much diluent you use. The second is whether you gave the vial its full two hours to hydrate.
Build the wait into your scheduling rather than around it. Mix at the start of the session block, label the vial with the time, and use the suspension inside 72 hours. Then hand the patient a written aftercare sheet. Their five days of massage matter as much as your ten minutes in the room. Tell them it begins once the first day has settled.
Track the series properly and the maintenance visit takes care of itself. Book a demo to see how Pabau records injection maps, stores treatment photos and automates Olidia aftercare for aesthetic practices.
Continue your research
Need a structured aesthetic consultation framework? Preparing for cosmetic client consultations guides practitioners through pre-treatment discovery and expectation-setting for injectable treatments.
Want to improve multi-session patient adherence? Reducing patient no-show rates covers the workflow changes that get clients through a full PLLA treatment series.
Looking for practice branding guidance? Medical spa branding tips helps aesthetic practices show their injectable expertise and build trust locally.
Combining injectables with energy-based devices? Nuera Tight aftercare sets out that treatment’s recovery window, so you can plan the two schedules around each other.
Documenting another injectable treatment? Silikon 1000 aftercare covers the patient instructions and follow-up schedule for a permanent filler.
Frequently asked questions
What is Olidia PLLA filler?
Olidia PLLA is a poly-L-lactic acid biostimulator filler that stimulates the patient’s own collagen production. It ships as a 365mg lyophilized powder vial containing 150mg of PLLA. Reconstituted and injected subcutaneously, it delivers gradual volume and skin quality improvement over 6 to 12 weeks.
How does Olidia compare to Sculptra?
Both are lyophilized PLLA biostimulators with the same mechanism and the same 150mg PLLA dose per vial. Expected duration is 18 to 24 months for either product. The differences are regulatory and practical. Sculptra is FDA approved in the United States, while Olidia is Korean MFDS approved and CE marked.
How long do Olidia PLLA results last?
Results develop gradually over 3 to 4 weeks and peak at 8 to 12 weeks after injection. Expected duration is 18 to 24 months. Longevity varies with metabolism and individual collagen response. Maintenance sessions every 12 to 18 months sustain the result beyond that window.
What are the side effects of an Olidia injection?
Common side effects are mild bruising, swelling and erythema, which usually resolve within 7 to 10 days. Rarer events include transient nodules, which respond to massage, and granuloma, which occurs in under 1% of cases with sound technique. Granulomas respond to intralesional corticosteroid injection or observation.
Is Olidia safe for all skin types?
Olidia PLLA suits most skin types, but screen for contraindications first: active inflammation, pregnancy, keloid tendency and immunosuppression. Darker skin types can see transient hyperpigmentation after treatment. Record baseline status in structured intake forms and set expectations against the patient’s starting point.